21.09 - 23.09.2017  STATUS

The meeting will be held in MADRID, SPAIN, from September 21st until September 23rd 2017. Worldwide experts in fundamental and applied aspects of myeloid cell biology in health and disease will be joining us as you can see in the enclosed program.

The program will also include short presentations based on abstract submission as well as poster sessions. We encourage you to submit an abstract describing your work for many available slots of oral (up to 15) and poster presentations. There are several options for travel grant support for young researchers. Take advantage of the ´early bird´ promotions!
Please visit our website and welcome all of you to join this interesting meeting!!

-Luke O´Neill, Trinity College Dublin, Ireland.
-Edward Pearce, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
-Mihai Netea, Radboud University Nijmegen, The Netherlands.
-Philippe Bousso, Institut Pasteur, Paris, France.
-Carlos Ardavín, Centro Nacional de Biotecnologia, Madrid, Spain.
-Maria Rescigno, Istituto Europeo di Oncologia, Milan, Italy.
-Christopher K. Glass, UC San Diego, California, USA.
-Gioacchino Natoli, Istituto Europeo di Oncologia, Milan, Italy.
-Michel Gilliet, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
-Veit Hornung, Ludwig-Maximilians-University Munich, Germany.
-Miriam Merad, Icahn School of Medicine at Mount Sinai, New York, USA.
-Filip Swirski, Massachusetts General Hospital and Harvard Medical School, Boston, USA.
-Michael Heneka, University of Bonn, Germany.
-Caetano Reis e Sousa, The Francis Crick Institute, London, UK.
-Sebastian Amigorena, Institut Curie, Paris, France.
-Ignacio Melero, Universidad Clínica de Navarra, CIMA, Pamplona, Spain.
-Jolanda de Vries, Radboud Univ. Nijmegen, The Netherlands.

Looking forward to seeing you in MADRID!!!,

The Organizing Committee
Amaya Puig-Kröger
Antonio Castrillo
David Sancho

Download program

Socios Protectores